Pelago Bioscience AB:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Pelago Bioscience AB - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11277
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:19
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スウェーデン
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Pelago Bioscience AB (Pelago Bioscience) is a developer of patented cellular thermal shift assay for use in determination and quantification of drug–target interactions. The company utilizes patented CETSA technology which enables direct, in situ physiologically relevant measurements of target engagement on target proteins in lysate, intact cells and tissue samples. Pelago Bioscience delivers in situ target studies to accelerate the preclinical and clinical drug discovery and diagnostics development. Pelago Bioscience’s services include assay development and screening services, and un-biased proteomic profiling. The company’s CETSA data and applications helps in drug discovery research and development companies to make better and more informed decisions at earlier stages in their projects. Pelago Bioscience is headquartered in Solna, Sweden.

Pelago Bioscience AB – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Pelago Bioscience AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Pelago Bioscience AB, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Pelago Bioscience AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Pelago Bioscience AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Pelago Bioscience AB, Medical Devices Deals, 2012 to YTD 2018 9
Pelago Bioscience AB, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Pelago Bioscience AB, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
WuXi AppTec to Partner with Pelago Bioscience 11
Biovica Enters into Agreement with Pelago Bioscience 12
Licensing Agreements 13
Pelago Bioscience Enters into Licensing Agreement with OmicScouts 13
GlaxoSmithKline Enters into Licensing Agreement with Pelago Bioscience for CETSA 14
Karo Bio Enters into Licensing Agreement with Pelago Bioscience for CETSA 15
Pelago Bioscience AB – Key Competitors 16
Pelago Bioscience AB – Key Employees 17
Pelago Bioscience AB – Locations And Subsidiaries 18
Head Office 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19

List of Tables
Pelago Bioscience AB, Pharmaceuticals & Healthcare, Key Facts 2
Pelago Bioscience AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Pelago Bioscience AB, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Pelago Bioscience AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Pelago Bioscience AB, Deals By Therapy Area, 2012 to YTD 2018 8
Pelago Bioscience AB, Medical Devices Deals, 2012 to YTD 2018 9
Pelago Bioscience AB, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
WuXi AppTec to Partner with Pelago Bioscience 11
Biovica Enters into Agreement with Pelago Bioscience 12
Pelago Bioscience Enters into Licensing Agreement with OmicScouts 13
GlaxoSmithKline Enters into Licensing Agreement with Pelago Bioscience for CETSA 14
Karo Bio Enters into Licensing Agreement with Pelago Bioscience for CETSA 15
Pelago Bioscience AB, Key Competitors 16
Pelago Bioscience AB, Key Employees 17

List of Figures
Pelago Bioscience AB, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Pelago Bioscience AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Pelago Bioscience AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Pelago Bioscience AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Pelago Bioscience AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Pelago Bioscience AB, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Pelago Bioscience AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Pelago Bioscience AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Pelago Bioscience AB, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Pelago Bioscience AB:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • PZ Cussons Nigeria Plc:企業の戦略・SWOT・財務情報
    PZ Cussons Nigeria Plc - Strategy, SWOT and Corporate Finance Report Summary PZ Cussons Nigeria Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Rafako SA (RFK):企業の財務・戦略的SWOT分析
    Rafako SA (RFK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Aixtron SE (AIXA):企業の財務・戦略的SWOT分析
    Aixtron SE (AIXA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Yue Yuen Industrial (Holdings) Limited:企業の戦略・SWOT・財務情報
    Yue Yuen Industrial (Holdings) Limited - Strategy, SWOT and Corporate Finance Report Summary Yue Yuen Industrial (Holdings) Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT ana …
  • Qaf Limited
    Qaf Limited - Strategy, SWOT and Corporate Finance Report Summary Qaf Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Glencore Plc:企業のM&A・事業提携・投資動向
    Glencore Plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Glencore Plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, …
  • American Outdoor Brands Corp:企業の戦略・SWOT・財務分析
    American Outdoor Brands Corp - Strategy, SWOT and Corporate Finance Report Summary American Outdoor Brands Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • NBCUniversal Media LLC:企業の戦略・SWOT・財務情報
    NBCUniversal Media LLC - Strategy, SWOT and Corporate Finance Report Summary NBCUniversal Media LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Solvay Group:企業の戦略・SWOT・財務情報
    Solvay Group - Strategy, SWOT and Corporate Finance Report Summary Solvay Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Caprion Biosciences Inc:医療機器:M&Aディール及び事業提携情報
    Summary Caprion Biosciences Inc (Caprion) is a provider of proteomics and immune monitoring services. The company provides proteomic based services such as neo-epitope discovery and characterization, biomarker discovery, fit-for-purpose assays, host cell protein detection, PK assays, and others. It …
  • Aksigorta A.S. (AKGRT):企業の財務・戦略的SWOT分析
    Aksigorta A.S. (AKGRT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Virginia Electric and Power Company:企業の発電所・SWOT分析2018
    Virginia Electric and Power Company - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information …
  • TransAlta Corporation (TA)-エネルギー分野:企業M&A・提携分析
    Summary TransAlta Corporation (TransAlta) is an electricity generation company. It generates electricity from a contracted portfolio of assets using diverse sources such as coal, natural gas, hydro, wind and geothermal. TransAlta's service portfolio comprises commercial and industrial energy service …
  • The Council of Europe Development Bank:企業の戦略・SWOT・財務分析
    The Council of Europe Development Bank - Strategy, SWOT and Corporate Finance Report Summary The Council of Europe Development Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT ana …
  • Bristow Group, Inc.:戦略・SWOT・企業財務分析
    Bristow Group, Inc. - Strategy, SWOT and Corporate Finance Report Summary Bristow Group, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • BrainStorm Cell Therapeutics Inc (BCLI):企業の財務・戦略的SWOT分析
    Summary BrainStorm Cell Therapeutics Inc (BrainStorm Cell Therapeutics) formerly Golden Hand Resources Inc is a biotechnology company which develops autologous stem cell therapies for neurodegenerative diseases. Its pipeline mesenchymal stem cell products are being developed based on cell therapy pl …
  • Bank Of Panhsin
    Bank Of Panhsin - Strategy, SWOT and Corporate Finance Report Summary Bank Of Panhsin - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Nimbus Therapeutics LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary Nimbus Therapeutics LLC (Nimbus Therapeutics), formerly Nimbus Discovery LLC, is a biotechnology company that develops medicines for critical diseases such as metabolic disease, cancer, and immune-inflammatory disorders. The company harnesses its expertise in deep computational chemistry to …
  • PT Perusahaan Listrik Negara (Persero) Tbk:戦略・SWOT・企業財務分析
    PT Perusahaan Listrik Negara (Persero) Tbk - Strategy, SWOT and Corporate Finance Report Summary PT Perusahaan Listrik Negara (Persero) Tbk - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, …
  • Berkshire Hathaway Inc:戦略・SWOT・企業財務分析
    Berkshire Hathaway Inc - Strategy, SWOT and Corporate Finance Report Summary Berkshire Hathaway Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆